MEK inhibitors: a new class of chemotherapeutic agents with ocular toxicity.

Duncan, K E; Chang, L Y; Patronas, M

Duncan, K E; Chang, L Y; Patronas, M.

Affiliation

Duncan KE; Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.
Chang LY; University of Maryland School of Medicine, Baltimore, MD, USA.
Patronas M; Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.

Eye (Lond) ; 29(8): 1003-12, 2015 Aug.

Article in En | MEDLINE | ID: mdl-26043707

Subject(s)

Antineoplastic Agents/adverse effects; Mitogen-Activated Protein Kinases/antagonists & inhibitors; Protein Kinase Inhibitors/adverse effects; Retinal Diseases/chemically induced; Female; Humans; Macular Edema/chemically induced; Male; Middle Aged

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinal Diseases / Mitogen-Activated Protein Kinases / Protein Kinase Inhibitors / Antineoplastic Agents Limits: Female / Humans / Male / Middle aged Language: En Journal: Eye (Lond) Year: 2015 Document type: Article

Fulltext

XML

PubMed Links

Search on Google